Mesangial cells initiate compensatory tubular cell hypertrophy

American Journal of Nephrology

Volumn 31, Issue 4, 2010, Pages 326-331

  Sinuani, I ^a   Beberashvili, I ^a   Averbukh, Z ^a   Cohn, M ^a   Gitelman, I ^b   Weissgarten, J ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Cell cycle; Compensatory growth; Growth factors; Hypertrophy; Mesangial cells; Tubular cell; Unilateral nephrectomy

Indexed keywords

COLLAGEN TYPE 1; CYCLIN E; FIBRONECTIN; HEAT SHOCK PROTEIN 70; PROTEIN C JUN; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR ERG; TRANSFORMING GROWTH FACTOR BETA; WT1 PROTEIN;

KIDNEY HYPERTROPHY; MESANGIUM CELL; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; HUMANS; HYPERTROPHY; KIDNEY; KIDNEY TUBULES; MESANGIAL CELLS;

EID: 76549122544     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000287229     Document Type: Review

References (67)

1. Aristotle: Generation of animals (translated by Peck AL). Cambridge, Harvard University Press, 1942, p 429.
2. Rhodius J: Mantissa anatomica ad Thomam Bartholinium. Copenhagen, P Haubold, 1661. Referenced after Nowinsky WW: Early history of renal hypertrophy; in Nowinsky WW, Goss RJ (eds): Compensatory Renal Growth. New York, Academic Press, 1969, pp 1-8.
3. Wesson LG: Compensatory growth and other growth responses of the kidney. Nephron 1989; 51: 149-184.
4. Fine LG, Norman JT: Renal growth responses to acute and chronic injury: routes to therapeutic intervention. J Am Soc Nephrol 1992; 2:S202-S211.
5. Stockand JD, Sansom SC: Glomerular mesangial cells: electrophysiology and regulation of contraction. Physiol Rev 1998; 78: 723-744.
6. Schena FP, Strippoli GF, Wankelmuth P: Renal growth factors: past, present and future. Am J Nephrol 1999; 19: 308-312.
7. Moskowitz DW, Liu W: Gene expression after unilateral nephrectomy in the rat: simultaneous expression of positive and negative growth control elements. J Urol 1995; 154: 1560-1565.
8. Liu B, Preisig PA: Compensatory renal tubular hypertrophy is mediated by a cell cycledependent mechanism. Kidney Int 2002; 62: 1650-1657.
9. Shankland SJ: Cell cycle regulatory proteins in glomerular disease. Kidney Int 1999; 56: 1208-1215.
10. Wolf G: Molecular mechanisms of renal hypertrophy: role of p27kip1. Kidney Int 1999; 56: 1262-1265. (Pubitemid 29451225)
11. Kitagawa M, Higashi H, Jung HK: The consensus motif for phosphorylation by cyclin D1-cdk4 is different from that for phosphorylation by cyclinA/E-cdk2. EMBO J 1996; 15: 7060-7069.
12. Connell-Crowley L, Harper JW, Goodrich DW: Cyclin D/cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by sitespecific phosphorylation. Mol Biol Cell 1997; 8: 287-301.
13. Lundberg AS, Weinberg RA: Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 1998; 18: 753-761.
14. Ezhevsky SA, Nagahara H, Vocero-Akbani AM, Glus DR, Wel MC, Dowdy SF: Hypophosphorylation of the retinoblastoma protein (pRB) by cyclin D-cdk 4,6 complexes results in active pRB. Proc Natl Acad Sci USA 1997; 94: 10699-10704.
15. Morgan DO: Principles of CDK regulation. Nature 1995; 374: 131-134.
16. Shankland SJ, Pippin J, Flanagan M, Coats SR, Nangaku M, Gordon KL, Roberts JM, Couser WG, Johnson RJ: Mesangial cell proliferation mediated by PDGF and bFGF is determined by levels of the cyclin kinase inhibitor p27kip1. Kidney Int 1997; 51: 1088-1099.
17. Wolf G, Nelson EG: Molecular mechanisms of tubulointerstitial hypertrophy and hyperplasia. Kidney Int 1991; 39: 401-420.
18. Liu B, Preisig PA: TGF-mediated hypertrophy in rat renal epithelial cells involves inhibiting phosphorylation by preventing activation of cdk2/cyclin E kinase. Am J Physiol 1999; 277:F186-F194.
19. Shankland SJ, Hamel PA, Scholey JW: Cyclin and cyclin dependent kinase expression in the remnant glomerulus. J Am Soc Nephrol 1996; 8: 368-375.
20. Park SK, Kang SK, Lee DY, Kang MJ, Kim SH, Kon GY: Temporal expression of cyclins and cyclin dependent kinases during renal development and compensatory growth. Kidney Int 1997; 51: 762-769.
21. Blobe GC, Schiemann WP, Lodish FH: Role of transforming growth factor in human disease. N Engl J Med 2000; 342: 1350-1358.
22. Bottinger EP: TGF in renal injury and disease. Semin Nephrol 2007; 27: 309-320.
23. Chen S, Jim B, Ziyadeh FN: Diabetic nephropathy and transforming growth factorbeta: transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol 2003; 23: 532-543.
24. Liu Y: Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2005; 69: 213-217.
25. Heldin CH, Landström M, Moustakas A: Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol 2009; 21: 166-176.
26. Franch HA, Shay JW, Alpern RJ, Preisig PA: Involvment of pRb family in TGF dependent epithelial cell hypertrophy. J Cell Biol 1995; 129: 245-254.
27. Fujita H, Omori S, Ishikura K, Hida M, Awazu M: ERK and p38 mediated high-glucoseinduced hypertrophy and TGF-beta expression in renal tubular cells. Am J Physiol Renal Physiol 2004; 286:F120-F126.
28. Wolf G, Mueller E, Stahl RA, Ziyadeh FN: Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta. J Clin Invest 1993; 92: 1366-1372.
29. Sinuani I, Averbukh Z, Gitelman I, Rapoport MJ, Sandbank J, Albeck M, Sredni B, Weissgarten J: Mesangial cells initiate compensatory renal tubular hypertrophy via IL-10 induced TGF secretion: effect of the immunomodulator AS101 on this process. Am J Physiol Renal Physiol 2006; 291:F384-F394.
30. Franch HA, Curtis PV, Mitch WE: Mechanisms of renal tubular cell hypertrophy: mitogen- induced suppression of proteolysis. Am J Physiol 1997; 273:C843-C851.
31. Nagahara H, Ezhevsky SA, Vocero-Akbani AM, Kaldis P, Solomon MJ, Dowdy SF: Transforming growth factor targeted inactivation of cyclin E: cyclin-dependent kinase 2 (Cdk2) complexes by inhibition of Cdk2 activating kinase activity. Proc Natl Acad Sci USA 1999; 96: 14961-14966.
32. Scandura JM, Boccuni P, Massaque J, Niemer SD: Transforming growth factor-induced cell cycle arrest of hematopoietic cells requires p57kip2 up-regulation. Proc Natl Acad Sci USA 2004; 101: 15231-15236.
33. Chen Z, Li DQ, Tong L, Stewart P, Chu C, Pflugfelder SC: Targeted inhibition of p57 and p15 blocks transforming growth factor beta-inhibited proliferation of primary cultured human limbal epithelial cells. Mol Vis 2006; 23: 983-994.
34. Sinuani I, Weissgarten J, Beberashvili I, Rapoport MJ, Sandbank J, Feldman L, Albeck M, Averbukh Z, Sredni B: The cyclin kinase inhibitor p57kip2 regulates TGF-beta- induced compensatory tubular hypertrophy: effect of the immunomodulator AS101. Nephrol Dial Transplant 2009; 24: 2328-2338.
35. Massague J: The transforming growth factor-family. Annu Rev Cell Biol 1990; 6: 597-631.
36. Han DC, Hoffman BB, Hong SW, Guo J, Ziyadeh FN: Therapy with antisense TGF-beta1 oligonucleotudes reduces kidney weight and matrix mRNAs in diabetic mice. Am J Physiol Renal Physiol 2000; 278:F628-F634.
37. Gorelik L, Flavell RA: Transforming growth factor-in T-cell biology. Nat Rev Immunol 2002; 2: 46-53.
38. Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, Dolganov G, Glick A, Sheppard D: Loss of integrin alpha(v)beta 6-mediated TGF-beta activation causes MMP 12-dependent emphysema. Nature 2003; 13: 422: 130-131.
39. Wynn T: Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214: 199-210.
40. Latta H, Fligiel S: Mesangial fenestrations, sieving, filtration, and flow. Lab Invest 1985; 29: 591-598.
41. Ling BN, Matsunaga H, Ma H, Eaton DC: Role of growth factors in mesangial cell ion channel regulation. Kidney Int 1995; 48: 1158-1166.
42. Schlöndorff D, Banas B: The mesangial cell revisited: no cell is an island. J Am Soc Nephrol 2009; 20: 1179-1187.
43. Banas B, Luckow B, Moller M, Kleir C, Nelson PJ, Schadde E, Brigl M, Halevy D, Holthofer L, Reinhart B, Schlondoff D: Chemokine and chemokine receptor expression in a novel mesangial cell line. J Am Soc Nephrol 1999; 10: 2314-2322.
44. Chadban SJ, Tesch GH, Foti R, Atkins RC, Nikolic-Paterson DJ: Interleukin-10 is a mesangial cell growth factor in vitro and in vivo. Lab Invest 1997; 76: 619-627.
45. Cove-Smith A, Hendry BM: The regulation of mesangial cell proliferation. Exp Nephrol 2008; 108: 74-79.
46. Schocklmann HO, Lang S, Sterzel RB: Regulation of mesangial cell proliferation. Kidney Int 1999; 56: 1199-1207.
47. Choi ME, Kim EG, Huang Q, Ballermann BJ: Rat mesangial cell hypertrophy in response to transforming growth factor-beta 1. Kidney Int 1993; 44: 948-958.
48. Flyvbjerg A, Bennett WF, Rasch R, van Neck JW, Groffen CA, Kopchick JJ, Scarlett JA: Compensatory renal growth in uninephrectomized adult mice is growth hormone dependent. Kidney Int 1999; 56: 2048-2052.
49. Mulroney SE, Scikos T, Koenig JI, Pesce C, Striker L, LeRoith D, Haramati A: Temporal increases in renal IGF-1, c-fos, and c-jun gene expression during hyperplastic kidney growth in weanling rats. Endocrinology 1996; 137: 839-845.
50. Johnson RJ: Cytokines, growth factors and renal injury: where do we go now? Kidney Int 1997; 52(suppl 63):2-6.
51. Averbukh Z, Berman S, Weissgarten J, Cohn M, Golik A, Cohen N, Shaked U, Modai D: Paradoxical effect of unilateral nephrectomy on serum atrial natriuretic peptide in rats. Ren Physiol Biochem 1994; 17: 101-107.
52. Averbukh Z, Berman S, Weissgarten J, Cohn M, Golik A, Cohen N, Modai D: Postnephrectomy mesangial cells secrete a factor(s) that stimulate(s) tubular cell growth in vitro. Nephron 1992; 60: 216-219.
53. Kaname S, Uchida S, Ogata E, Kurokawa K: Autocrine secretion of TGF in cultured rat mesangial cells. Kidney Int 1992; 42: 1319-1324.
54. Kitamura M, Suto Y, Yokoo T, Shimizu F, Fine LG: TGF is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells. J Immunol 1996; 156: 2964-2971.
55. Wolf G, Ziyadeh FN, Zahner G, Stahl RA: Angiotensin II-stimulated expression of transforming growth factor beta in renal proximal tubular cells: attenuation after stable transfection with the c-mas oncogene. Kidney Int 1995; 48: 1818-1827.
56. Song K, Cornelius SC, Reiss M, Danielpour D: Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2. J Biol Chem 2003; 278: 38342-38351.
57. Sullivan DE, Ferris M, Pociak D, Brody AR: The latent form of TGF-beta(1) is induced by TNFalpha through an ERK specific pathway and is activated by asbestos-derived reactive oxygen species in vitro and in vivo. J Immunotoxicol 2008; 5: 145-149.
58. Hardie WD, Davidson C, Ikegami M, Leikauf GD, Le Cras TD, Prestidge A, Whitsett JA, Korfhagen TR: EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-alpha-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2008; 294:L1217-L1225.
59. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209-1220.
60. Gerritsma JS, Gerritsen AF, Van Kooten C, Van Es LA, Daha MR: Interleukin-1-alpha enhances the biosynthesis of complement C3 and factor B by human kidney proximal tubular epithelial cells in vitro. Mol Immunol 1996; 33: 847-854.
61. Riemann D, Kehlen A, Langner J: Stimulation of the expression and the enzyme activity of aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 on human renal cell carcinoma cells and renal tubular epithelial cells by T cell-derived cytokines, such as IL-4 and IL-13. Clin Exp Immunol 1995; 100: 277-283.
62. Niemir ZI, Ondracek M, Dworacki G, Stein H, Waldherr R, Ritz E, Otto HF: In situ upregulation of IL-10 reflects the activity of human glomerulonephritides. Am J Kidney Dis 1998; 32: 80-92.
63. Wolf G: Cell cycle regulation in diabetic nephropathy. Kidney Int Suppl 2000; 77:S59-S64.
64. Sterzel RB, Schulze-Lohoff E, Weber M, Goodman SL: Interactions between glomerular mesangial cells, cytokines and extracellular matrix. J Am Soc Nephrol 1992; 2:S126-S131.
65. Kanwar YS, Wada J, Sun L, Xie P, Wallner EL, Chen S, Chugh S, Danesh FR: Diabetic nephropathy: mechanism of renal disease progression. Exp Biol Med 2008; 233: 4-11.
66. Schena FP, Gesualdo L: Pathogenetic mechanism of diabetic nephropathy. J Am Soc Nephrol 2005; 16:S30-S33.
67. Brown Z, Robson RL, Westwick J: Regulation and expression of chemokines: potential role in glomerulonephritis. J Leukoc Biol 1996; 59: 75-80.